Jiangsu Jibeier Pharmaceutical Co.,Ltd.’s Net Profit Rose 129.3% in First Half of 2023

Jiangsu Jibeier Pharmaceutical Co.,Ltd. (江苏吉贝尔药业股份有限公司) (688566.SH) reported a net profit of 96.1 million yuan in the first half of 2023, up 129.3% year-on-year.

Meanwhile, the company posted 418.8 million yuan in revenue, up 62.8% year-on-year.

At the end of the reporting period, it had 2 billion yuan in total assets and 288.9 million yuan in total liabilities, with a liability-to-asset ratio of 14.1%.